She wore a variety of bright sneakers and occasionally did a cha-cha-cha in them. Her laughter was contagious. Patients ...

Treatment with givinostat has received fast track designation from the United States Food and Drug Administration for ...

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...

Dr. Cathy Eng discusses data that led to the FDA approval of Braftovi and Erbitux plus chemo for metastatic colorectal cancer ...

Bladder preservation for bladder cancer requires balancing clinical factors and patient health with a personalized treatment ...

Dr. Shirley D'Sa discusses the importance of catching peripheral neuropathy in patients with Waldenstrom macroglobulinemia ...

Michi has been an oncology nurse for more than 20 years and continues to make an impact in the field. Michi has expertise in ...

First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and ...

An AI model using serial brain scans predicted glioma recurrence in children with up to 89% accuracy, outperforming ...

Discrepancies between patients' experiences and friends' lives can strain relationships, highlighting the need for ...

In this Q&A, Carly Stafford Dixon discusses her lymphoma journey, recovery with CAR T therapy, and mission to raise support ...

Dr. Cathy Eng discusses the importance of the Braftovi plus Erbitux FDA approval for treatment-naive BRAF V600E+ metastatic ...